Opportunity Information: Apply for CDC RFA GH21 2148
This funding opportunity, titled "Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR)," is a CDC cooperative agreement (Funding Opportunity Number CDC RFA GH21 2148) focused on improving the quality and usefulness of HIV program data and strengthening service delivery support systems in Angola. It sits within the U.S. Department of Health and Human Services, Centers for Disease Control and Prevention (CDC), under the broader PEPFAR framework. The program is positioned as a continuation and enhancement of ongoing work with Angola's national public health laboratory institute (INLS), with the overall intent of improving oversight, measurement, and performance of HIV services at both national and provincial levels.
The public health need described in the notice is grounded in multiple recent surveillance sources showing that Angola's HIV epidemic is generalized and primarily driven by heterosexual transmission. The notice cites three population-based studies: the 2016 Demographic and Health Survey (DHS), the 2016 Integrated Bio-behavioral Surveillance Survey (IBBS), and the 2015 Seroprevalence and Behavioral Epidemiological Risk Survey (SABERS). DHS estimates overall adult HIV prevalence at 2.0 percent among people ages 15 to 49, with a notable gender gap: prevalence among women in this age range is higher than among men (2.6 percent versus 1.2 percent). The opportunity also highlights strong geographic variation, emphasizing that HIV burden is not evenly distributed across the country. While Luanda is reported at 1.9 percent, several provinces meet or exceed 4.0 percent prevalence, including Cunene (6.1 percent), Cuando Cubango (5.5 percent), and Moxico (4.0 percent). These details are used to justify a stronger strategic information and laboratory backbone so that programs can better target services and track progress toward epidemic control.
In terms of what the award would support, the notice stresses strategic activities intended to produce more accurate program data and improve understanding of the epidemic. In practice, this points to investments in strategic information (SI) systems and the kind of monitoring, evaluation, and data quality improvements that allow decision-makers to see what is working, where gaps exist, and how resources should be prioritized. The NOFO is designed to reinforce the underlying systems that make HIV programs function well: stronger health systems oversight, more reliable reporting and analysis, and better integration of information across service areas so that program performance can be measured and improved over time.
A major component is laboratory support and related technical assistance. While the notice does not list every laboratory activity in detail, the emphasis on laboratory services and opportunistic infection-related services suggests support for strengthening diagnostic networks and quality systems that underpin HIV testing and treatment monitoring. This can include improving laboratory procedures, strengthening quality assurance and quality management, supporting referral and sample transport practices where relevant, and ensuring laboratory outputs are consistent enough to be used confidently for clinical and program decisions. The program is also framed as supporting oversight of HIV-related services, which implies a hands-on technical assistance approach rather than a simple pass-through grant, consistent with the cooperative agreement funding instrument.
The scope of HIV services referenced is broad and includes HIV counseling and testing, prevention of mother-to-child transmission (PMTCT), and other HIV and opportunistic infection services. By naming these service areas alongside strategic information and laboratory strengthening, the notice signals that the award is meant to improve the full chain from service delivery to measurement: better testing and PMTCT implementation, better lab support behind those services, and better data systems to track coverage, quality, and outcomes. The intended end result is improved quality of HIV care and treatment services and, ultimately, contribution to HIV epidemic control in Angola through better informed planning and stronger program execution.
Funding and administrative details are straightforward. The cooperative agreement is listed as discretionary funding under CFDA 93.067. CDC anticipates approximately $300,000 in total fiscal year funding for Year 1, contingent on availability of funds, and expects to make one award. The listing notes an "Award Ceiling for Year 1" of $0 (none), which typically means no maximum cap is specified in the announcement even though an approximate amount is provided. The opportunity was created March 1, 2021, with an original application closing date of April 30, 2021, and electronic submissions due by 11:59 p.m. Eastern Time on the deadline. Eligibility is described as "Others," with additional eligibility specifics referenced as being provided in an "Additional Information on Eligibility" section in the full announcement.
Overall, the opportunity is best understood as a targeted PEPFAR-aligned investment aimed at strengthening the core technical infrastructure of Angola's HIV response: strategic information systems that generate trustworthy program intelligence, laboratory systems that support accurate diagnosis and monitoring, and sustained technical assistance that improves oversight and performance across key HIV service areas such as testing and PMTCT, with special relevance for provinces experiencing higher HIV prevalence and for addressing the higher burden observed among women.Apply for CDC RFA GH21 2148
- The Department of Health and Human Services, Centers for Disease Control - CGH in the health sector is offering a public funding opportunity titled "Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR)" and is now available to receive applicants.
- Interested and eligible applicants and submit their applications by referencing the CFDA number(s): 93.067.
- This funding opportunity was created on Mar 01, 2021.
- Applicants must submit their applications by Apr 30, 2021 Electronically submitted applications must be submitted no later than 1159 p.m., ET, on the listed application due date.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Frequently Asked Questions (FAQs)
What is the title of this funding opportunity?
The funding opportunity is titled "Strengthening HIV/AIDS-related Strategic Information, Laboratory Support, and Technical Assistance Services in Angola under the President's Emergency Plan for AIDS Relief (PEPFAR)."
Which agency is offering this opportunity?
This is a U.S. Department of Health and Human Services opportunity offered through the Centers for Disease Control and Prevention (CDC), under the broader PEPFAR framework.
What type of funding instrument is this?
The notice describes this as a CDC cooperative agreement. A cooperative agreement generally indicates CDC expects to have substantial involvement in the supported work, consistent with the technical assistance and oversight focus described in the opportunity.
What is the Funding Opportunity Number (FON)?
The Funding Opportunity Number is CDC RFA GH21 2148.
What is the CFDA number listed for this opportunity?
The opportunity is listed under CFDA 93.067.
What is the overall purpose of the award?
The overall purpose is to improve the quality and usefulness of HIV program data and to strengthen service delivery support systems in Angola, with a focus on strategic information, laboratory support, and technical assistance that improve oversight, measurement, and performance of HIV services at national and provincial levels.
How does this opportunity relate to PEPFAR?
The opportunity is explicitly positioned under the President's Emergency Plan for AIDS Relief (PEPFAR) and is framed as a PEPFAR-aligned investment to strengthen the technical infrastructure that supports Angola's HIV response.
What public health need is described in the notice?
The notice describes Angola's HIV epidemic as generalized and primarily driven by heterosexual transmission. It cites multiple surveillance sources and emphasizes differences by sex and by geography, supporting the need for stronger strategic information and laboratory systems to better target services and track progress toward epidemic control.
Which surveillance sources are cited to support the need for this work?
The notice cites the 2016 Demographic and Health Survey (DHS), the 2016 Integrated Bio-behavioral Surveillance Survey (IBBS), and the 2015 Seroprevalence and Behavioral Epidemiological Risk Survey (SABERS).
What HIV prevalence estimate is provided for adults ages 15 to 49?
The notice references a DHS estimate of 2.0 percent HIV prevalence among people ages 15 to 49.
Does the notice describe differences in HIV prevalence between women and men?
Yes. For ages 15 to 49, the notice highlights higher prevalence among women compared to men (2.6 percent versus 1.2 percent).
Does the notice describe geographic variation in HIV burden within Angola?
Yes. The notice states that HIV burden is not evenly distributed across the country and provides examples of provincial variation.
Which provinces are highlighted as having higher HIV prevalence?
The notice highlights Cunene (6.1 percent), Cuando Cubango (5.5 percent), and Moxico (4.0 percent) as provinces meeting or exceeding 4.0 percent prevalence. It also provides a figure for Luanda (1.9 percent).
What kinds of activities are supported under the "strategic information" focus?
Based on the description provided, supported activities are intended to produce more accurate program data and improve understanding of the epidemic. This includes strengthening strategic information systems and related monitoring, evaluation, reporting, analysis, and data quality improvements so decision-makers can identify what is working, where gaps exist, and how to prioritize resources.
What is meant by strengthening oversight, measurement, and performance of HIV services?
As described, the opportunity aims to reinforce the systems used to monitor HIV services at national and provincial levels, improve the reliability and integration of reporting and analysis, and make it easier to measure program performance over time and use that information to improve service delivery.
What role does laboratory support play in this opportunity?
Laboratory support is described as a major component, paired with technical assistance. The emphasis is on strengthening laboratory services and related systems that underpin HIV testing and treatment monitoring, and on ensuring laboratory outputs are consistent and reliable enough for clinical and program decision-making.
Are specific laboratory activities listed?
The notice does not list every laboratory activity in detail, but it emphasizes laboratory services and opportunistic infection-related services, suggesting support for diagnostic networks and quality systems that backstop HIV service delivery.
What kinds of laboratory-strengthening elements are implied by the description?
The description suggests strengthening laboratory procedures, quality assurance and quality management, referral and sample transport practices where relevant, and overall reliability of laboratory outputs for program and clinical use.
What is the technical assistance component described in the opportunity?
The opportunity is framed as providing sustained technical assistance to improve oversight and performance of HIV-related services, consistent with a cooperative agreement structure that supports hands-on collaboration rather than a simple pass-through grant.
Which HIV service areas are referenced as within scope?
The notice references a broad scope of HIV services, including HIV counseling and testing, prevention of mother-to-child transmission (PMTCT), and other HIV and opportunistic infection services.
How do strategic information and laboratory strengthening connect to HIV services like testing and PMTCT?
The notice signals an intent to improve the full chain from service delivery to measurement: strengthening the services themselves (such as testing and PMTCT), strengthening the laboratory support behind those services, and strengthening the data systems used to track coverage, quality, and outcomes.
What is the intended end result of this award?
The intended end result is improved quality of HIV care and treatment services and a contribution to HIV epidemic control in Angola through better informed planning, stronger program execution, and stronger strategic information and laboratory systems.
Is this opportunity described as new work or a continuation of existing efforts?
It is positioned as a continuation and enhancement of ongoing work with Angola's national public health laboratory institute (INLS).
Which national institution in Angola is mentioned in the notice?
The notice references Angola's national public health laboratory institute (INLS).
How much funding is anticipated for Year 1?
CDC anticipates approximately $300,000 in total fiscal year funding for Year 1, contingent on the availability of funds.
How many awards does CDC expect to make?
The notice indicates CDC expects to make one award.
Is there an award ceiling for Year 1?
The listing notes an "Award Ceiling for Year 1" of $0 (none). This typically indicates that no maximum cap is specified in the announcement, even though an approximate funding level is provided.
What is the application deadline mentioned?
The original application closing date is April 30, 2021, with electronic submissions due by 11:59 p.m. Eastern Time on the deadline.
When was the opportunity created?
The opportunity was created on March 1, 2021.
What eligibility category is listed?
Eligibility is described as "Others," with additional details referenced as being provided in an "Additional Information on Eligibility" section in the full announcement.
Does the notice indicate special relevance for certain populations or areas?
Yes. The notice highlights higher HIV burden among women compared to men and emphasizes provinces with higher prevalence, underscoring the need for stronger systems to support targeted planning and performance monitoring in areas with greater burden.
What makes this opportunity primarily about systems strengthening rather than direct service delivery?
The notice emphasizes strengthening the "backbone" of HIV programs: strategic information systems (data quality, reporting, analysis, monitoring) and laboratory systems (quality systems and reliability of outputs), along with technical assistance to improve oversight and performance across HIV service areas.
Browse more opportunities from the same category: Health
Next opportunity: FY 2022 EducationUSA Advising Services
Previous opportunity: Supporting and Improving the Chronic Kidney Disease Surveillance System in the United States
Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for CDC RFA GH21 2148
Applicants also applied for:
Applicants who have applied for this opportunity (CDC RFA GH21 2148) also looked into and applied for these:
| Funding Opportunity |
|---|
| ACL National Falls Prevention Resource Center Apply for HHS 2021 ACL AOA FPSG 0019 Funding Number: HHS 2021 ACL AOA FPSG 0019 Agency: Department of Health and Human Services, Administration for Community Living Category: Health Funding Amount: $1,000,000 |
| Behavioral Health Workforce Development Technical Assistance and Evaluation (BHWD TAE) Program Apply for HRSA 21 086 Funding Number: HRSA 21 086 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Preventing Violence Affecting Young Lives (PREVAYL) Apply for CDC RFA CE21 2104 Funding Number: CDC RFA CE21 2104 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $250,000 |
| State Newborn Screening Interoperability Implementation Program Apply for HRSA 21 085 Funding Number: HRSA 21 085 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Long-term Follow-up for Severe Combined Immunodeficiency and Other Newborn Screening Conditions Apply for HRSA 21 079 Funding Number: HRSA 21 079 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: $500,000 |
| Strengthening the Provision of Accessible and Quality Assured Laboratory Services in Namibia through the Namibia Institute of Pathology for Sustained Epidemic Control of HIV and TB under PEPFAR Apply for CDC RFA GH21 2157 Funding Number: CDC RFA GH21 2157 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Strengthening Urban Health Services and Models of Care in Kampala Capital City Authority (KCCA)- Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2158 Funding Number: CDC RFA GH21 2158 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Technical Assistance (TA) to Support the Health Information Systems (HIS) of the South African Government to Improve Patient-level Data Systems at the National and Sub-National Departments of Health (DoH) under PEPFAR Apply for CDC RFA GH21 2123 Funding Number: CDC RFA GH21 2123 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Hospital Based Birth Defects Surveillance in Kampala, Uganda under the President's Emergency Plan for AIDS Relief (PEPFAR) Apply for CDC RFA GH21 2160 Funding Number: CDC RFA GH21 2160 Agency: Department of Health and Human Services, Centers for Disease Control - CGH Category: Health Funding Amount: Case Dependent |
| Surveillance and Response to Avian and Pandemic Influenza by National Health Authorities outside the United States Apply for CDC RFA IP21 2101 Funding Number: CDC RFA IP21 2101 Agency: Department of Health and Human Services, Centers for Disease Control - NCIRD Category: Health Funding Amount: Case Dependent |
| Integrated HIV Care and Treatment Support Activity Apply for 72061321RFA00006 Funding Number: 72061321RFA00006 Agency: Agency for International Development, Zimbabwe USAID-Harare Category: Health Funding Amount: $70,000,000 |
| Advancing Health Literacy to Enhance Equitable Community Responses to COVID-19 Apply for MP CPI 21 006 Funding Number: MP CPI 21 006 Agency: Department of Health and Human Services, Office of the Assistant Secretary for Health Category: Health Funding Amount: $4,000,000 |
| Strengthening Rocky Mountain spotted fever (RMSF) prevention and control in Arizona tribal lands Apply for CDC RFA CK21 2102 Funding Number: CDC RFA CK21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCEZID Category: Health Funding Amount: $350,000 |
| Rigorously Evaluating Programs and Policies to Prevent Child Sexual Abuse (CSA) Apply for RFA CE 21 006 Funding Number: RFA CE 21 006 Agency: Department of Health and Human Services, Centers for Disease Control and Prevention - ERA Category: Health Funding Amount: $400,000 |
| Quality Improvement Solutions for Sustained Epidemic Control Project (QISSEC) Apply for HRSA 21 096 Funding Number: HRSA 21 096 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Maximizing the Scientific Value of Existing Biospecimen Collections (R21 Clinical Trial Not Allowed) Apply for RFA OD 21 004 Funding Number: RFA OD 21 004 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
| Secondary Analyses of Existing Datasets of Tobacco Use and Health (R21 Clinical Trial Not Allowed) Apply for RFA OD 21 003 Funding Number: RFA OD 21 003 Agency: Department of Health and Human Services, National Institutes of Health Category: Health Funding Amount: $200,000 |
| Drug-Free Communities (DFC) Support Program Apply for CDC RFA CE21 2102 Funding Number: CDC RFA CE21 2102 Agency: Department of Health and Human Services, Centers for Disease Control - NCIPC Category: Health Funding Amount: $125,000 |
| Global Reach I Apply for HRSA 21 066 Funding Number: HRSA 21 066 Agency: Department of Health and Human Services, Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Emergency Triage, Treat, and Transport (ET3) Model Apply for CMS 2F2 21 001 Funding Number: CMS 2F2 21 001 Agency: Department of Health and Human Services, Centers for Medicare Medicaid Services Category: Health Funding Amount: $1,175,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Inside Our Applicants Portal
Access Applicants Portal
- Grants Repository - Access current and historic funding opportunities with ease. Thousands of funding opportunities are published every week. We can help you sort through the database and find the eligible ones to apply for.
- Applicant Video Guides - The grant application process can be challenging to follow. We can help you with intuitive video guides to speed up the process and eliminate errors in submissions.
- Grant Proposal Wizard - We have developed a network of private funding organizations and investors across the United States. We can reach out and submit your proposal to these contacts to maximize your chances of getting the funding you need.
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Learn More
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "CDC RFA GH21 2148", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.